Data demonstrate reduction in targeted and overall severity of CI in patients treated with topical IPEG™ TMB-001 (topical isotretinoin) Company planning for end-of-Phase 2 meeting with FDA in the beginning of 2022 Phase 3 study is expected to begin in Q2 2022 Basking Ridge, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE)… Read More..

Auddia presenting to the 1,500-station strong membership of the IBA in October BOULDER, CO / ACCESSWIRE / October 7, 2021 / Auddia Inc. (NASDAQ:AUUD)(NASDAQ:AUUDW) ("Auddia" or the "Company"), developer of a proprietary AI platform for audio and innovative technologies for podcasts that is reinventing how consumers engage with audio, today announced a… Read More..

Conference Call on Wednesday, October 13th, 2021 at 11:00am EST MILTON, NY - (NewMediaWire) - October 06, 2021 - Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its second quarter and first half… Read More..